Jennerex Receives $5,100,000 Series C Financing

  • Feed Type
  • Date
    8/13/2009
  • Company Name
    Jennerex
  • Mailing Address
    201 Mission Street San Francisco, CA 94105
  • Company Description
    Jennerex is named in honor of the legendary physician Dr. Edward Jenner. Dr. Jenner’s discovery led to eradication of the worst medical scourge in the history of the world: smallpox, a viral infection. He used a cowpox virus to vaccinate people and protect them against smallpox starting in 1796, and 200 years later smallpox was eradicated. The team of medical pioneers at Jennerex has now created therapeutics, from the same class of viruses discovered by Dr. Jenner, which are designed to eradicate cancer.
  • Website
    http://www.jennerex.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,100,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    The net proceeds of the private placement will be used to continue advancing the Company’s clinical development programs with the lead product JX-594.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy